A. Zenebergh
About
In The Last Decade
A. Zenebergh
27 papers receiving 817 citations
Peers
Comparison fields: 5 of 77
- Genetics 279
- Hematology 245
- Molecular Biology 187
- Oncology 159
- Pediatrics, Perinatology and Child Health 156
Countries citing papers authored by A. Zenebergh
This map shows the geographic impact of A. Zenebergh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Zenebergh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Zenebergh more than expected).
Fields of papers citing papers by A. Zenebergh
This network shows the impact of papers produced by A. Zenebergh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Zenebergh. The network helps show where A. Zenebergh may publish in the future.
Co-authorship network of co-authors of A. Zenebergh
This figure shows the co-authorship network connecting the top 25 collaborators of A. Zenebergh. A scholar is included among the top collaborators of A. Zenebergh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Zenebergh. A. Zenebergh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 14 | |
| 2 | 20 | |
| 3 | 228 | |
| 4 | 55 | |
| 5 | 2-Chlorodeoxyadenosine (CDA) therapy in chronic lymphocytic leukemia (CLL) and Waldenstrom's macroglobulinemia (WD): An update on 77 patients. | 1 |
| 6 | Long-term culture of autologous transplanted bone marrow for acute myeloid leukaemia: evidence for an in vitro haemopoietic defect and lack of correlation with the speed of engraftment. | 10 |
| 7 | 2-chloro-deoxyadenosine With Or Without Daunorubicin for Relapsing Or Refractory Acute Myeloblastic-leukemia | 1 |
| 8 | 2-chlorodeoxyadenosine Therapy in Non-hodgkins-lymphoma | 2 |
| 9 | 97 | |
| 10 | Uptake and Subcellular-localization of Fluoroquinolones in Macrophages | 2 |
| 11 | 114 | |
| 12 | 6 | |
| 13 | 8 | |
| 14 | Cellular pharmacokinetics of spiramycin in cultured macrophages. | 2 |
| 15 | 15 | |
| 16 | 6 | |
| 17 | 9 | |
| 18 | 5 | |
| 19 | 5 | |
| 20 | 3 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.